Company: BNRG
Filing Date: 2025-03-04
Form Type: 20-F
Source: 0001213900-25-020178
Chunk: 24

Company: Brenmiller Energy Ltd.
Filing Date: 2025-03-04
Form: 20-F
Item: Item 3
Chunk 24
---
 obtain a significant commercial advantage from the intellectual property that we develop or license.

Risks Related to Ownership
of our Securities

Nasdaq may delist
our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject
us to additional trading restrictions.

On
August 12, 2024, we received a written notice from the Nasdaq Stock Market LLC, or Nasdaq, indicating that we are not in compliance
with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities
to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), we were granted a grace period of 180 calendar
days to regain compliance with the minimum bid price requirement. On January 16, 2025, we announced that we received a written notice
from Nasdaq that we have regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing
Rule 5550(a)(2). The Nasdaq staff made this determination of compliance after the closing bid price of our ordinary shares on Nasdaq was
at $1.00 per share or greater for the 10 consecutive business days prior to the date of the notice. Accordingly, we have regained compliance
with Nasdaq Listing Rule 5550(a)(2), and Nasdaq considers the prior bid price deficiency matter now closed.

However,
there can be no assurance that we will be able to maintain compliance with the minimum bid price requirement or that we will otherwise
be in compliance with other Nasdaq listing criteria.

If,
for any reason, Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national
securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant
material adverse consequences, including:

  a limited availability of market quotations for  

  reduced liquidity for our securities;  

  a decrease in the number of institutional and                           
  general investors that will consider investing in our ordinary shares;  
 ──────────────────────────────────────────────────────────────────────────

  a determination that our ordinary shares are                                                                                     

  a limited amount of news and analyst coverage;  

  a reduction in the number of market makers for                                                                    

  a decreased ability to issue additional securities  
  or obtain additional financing in the future; and